Abstract:Various protocols have been proven effective in the directed differentiation of mouse and human pluripotent stem cells into skeletal muscles and used to study myogenesis. Current 2D myogenic differentiation protocols can mimic muscle development and its alteration under pathological conditions such as muscular dystrophies. 3D skeletal muscle differentiation approaches can, in addition, model the interaction between the various cell types within the developing organoid. Our protocol ensures the differentiation of human embryonic/induced pluripotent stem cells (hESC/hiPSC) into skeletal muscle organoids (SMO) via cells with paraxial mesoderm and neuromesodermal progenitors' identity and further production of organized structures of the neural plate margin and the dermomyotome. Continuous culturing omits neural lineage differentiation and promotes fetal myogenesis, including the maturation of fibroadipogenic progenitors and PAX7-positive myogenic progenitors. The PAX7 progenitors resemble the late fetal stages of human development and, based on single-cell transcriptomic profiling, cluster close to adult satellite cells of primary muscles. To overcome the limited availability of muscle biopsies from patients with muscular dystrophy during disease progression, we propose to use the SMO system, which delivers a stable population of skeletal muscle progenitors from patient-specific iPSCs to investigate human myogenesis in healthy and diseased conditions. Key features • Development of skeletal muscle organoid differentiation from human pluripotent stem cells, which recapitulates myogenesis. • Analysis of early embryonic and fetal myogenesis. • Provision of skeletal muscle progenitors for in vitro and in vivo analysis for up to 14 weeks of organoid culture. • In vitro myogenesis from patient-specific iPSCs allows to overcome the bottleneck of muscle biopsies of patients with pathological conditions.

Generating ventral spinal organoids from human induced pluripotent stem cells

Generation of dorsoventral human spinal cord organoids via functionalizing composite scaffold for drug testing

Bioengineering the human spinal cord

Human Placenta Decellularized Extracellular Matrix Hydrogel Promotes the Generation of Human Spinal Cord Organoids with Dorsoventral Organization from Human Induced Pluripotent Stem Cells

Generation of Neural Organoids for Spinal-Cord Regeneration Via the Direct Reprogramming of Human Astrocytes

Generation of human midbrain organoids from induced pluripotent stem cells

Generation of human region-specific brain organoids with medullary spinal trigeminal nuclei

Spinal Cord Organoids to Study Motor Neuron Development and Disease

Decellularized Brain Extracellular Matrix Hydrogel Aids the Formation of Human Spinal-Cord Organoids Recapitulating the Complex Three-Dimensional Organization

Spinal cord tissue engineering using human primary neural progenitor cells and astrocytes

Efficient generation of human cerebral organoids directly from adherent cultures of pluripotent stem cells

Generation of Functional Posterior Spinal Motor Neurons from Hpscs-Derived Human Spinal Cord Neural Progenitor Cells

Generation of Skeletal Muscle Organoids from Human Pluripotent Stem Cells

A Hollow Fiber System for Simple Generation of Human Brain Organoids

Ipscs-Derived Neurons and Brain Organoids from Patients.

A facile method to generate cerebral organoids from human pluripotent stem cells

Differentiation of brain and retinal organoids from confluent cultures of pluripotent stem cells connected by nerve-like axonal projections of optic origin

Brainstem Organoids From Human Pluripotent Stem Cells

Progress and challenges in directing the differentiation of human iPSCs into spinal motor neurons

Application of Human Brain Organoids—Opportunities and Challenges in Modeling Human Brain Development and Neurodevelopmental Diseases

Generation of Standardized and Reproducible Forebrain-type Cerebral Organoids from Human Induced Pluripotent Stem Cells